Health and well-being outcomes for drug-dependent offenders on the NSW Drug Court programme

Drug and Alcohol Review

Volumn 22, Issue 4, 2003, Pages 409-416

  Freeman, Karen ^a  

^a NSW Bureau of Crime Statistics and Research   (Australia)

Author keywords

Coerced treatment; Drug court; Drug dependent; Health; SF 36; Well being

Indexed keywords

STREET DRUG;

ADDICTION; ADOLESCENT; ADULT; ARTICLE; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH STATUS; HUMAN; JUVENILE DELINQUENCY; LEGAL ASPECT; MALE; MENTAL HEALTH SERVICE; MIDDLE AGED; OUTCOME ASSESSMENT; QUESTIONNAIRE; STATISTICS; SUBSTANCE ABUSE; URINE;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; JUVENILE DELINQUENCY; MALE; MENTAL HEALTH SERVICES; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION; QUESTIONNAIRES; STREET DRUGS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS;

EID: 0345547586     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/09595230310001613921     Document Type: Article

References (56)

1. Weatherburn D, Topp L, Midford R, Allsopp S. Drug crime prevention and mitigation: a literature review and research agenda. Sydney: New South Wales Bureau of Crime Statistics and Research, 2000.
2. Darke S, Swift W, Hall W. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 1994;89:211-7.
3. Gossop M, Marsden J, Stewart D, et al. Substance use, health and social problems of service users at 54 drug treatment agencies. Intake data from the National Treatment Outcome Research Study. Br J Psychiatry 1998;173:166-71.
4. Webster IM, Waddy N, Jenkins LV, Lai LY. Health status of a group of narcotic addicts in a methadone treatment programme. Med J Aust 1977;2:485-91.
5. Ryan CF, White JM. Health status at entry to methadone maintenance treatment using the SF-36 Health Survey questionnaire. Addiction 1996;91:39-45.
6. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (EGA) Study. JAMA 1990;264:2511-8.
7. Gerstein DR, Lewin LS. Treating drug problems. Volume 1: A study of effectiveness and financing of public and private drug treatment systems. Washington DC: Institute of Medicine, National Academy Press, 1990.
8. Mattick RP, Hall W. A treatment outline for approaches to opioid dependence: quality assurance project. Canberra: Australian Government Publishing Service, 1993.
9. Gossop M, Marsden J, Stewart D, Treacy S. Change and stability of change after treatment of drug misuse: 2-year outcomes from the National Treatment Outcome Research Study (UK). Addict Behav 2002;27:155-66.
10. Bell J, Ward J, Mattick R, Chan J, Hall W. An evaluation of private methadone clinics. Report no. 4. Canberra, 1996.
11. Anglin M, Hser Y. Treatment of drug abuse. In: Tonry M, Wilson JQ, editors. Drugs and crime. Crime and justice: a review of research. Chicago: University of Chicago Press, 1990.
12. Ward J, Mattick R, Hall W. Key issues in methadone maintenance. Sydney: University of New South Wales Press, 1992.
13. Hall W. Methadone maintenance treatment as a crime control measure. Report no. 66. Sydney: New South Wales Bureau of Crime Statistics and Research; 1996.
14. Hall W. The role of legal coercion in the treatment of offenders with alcohol and heroin problem. Aust NZ J Criminel 1997;30:103-20.
15. Freiberg A. Australian drug courts. Crim Law J 2000;24:213-35.
16. Office of Justice Programs Drug Court Clearing House and Technical Assistance Project. Looking at a decade of drug courts, Washington DC: Office of Justice Programs Drug Court Clearing House and Technical Assistance Project, American University, 1999.
17. Office of Justice Programs. Defining drug courts: the key components. Washington DC: US Department of Justice, 1997.
18. Hora P, Schma W, Rosenthal J. Therapeutic jurisprudence and the drug treatment court movement: revolutionizing the criminal justice system's response to drug abuse and crime in America. Notre Dame Law Rev 1999;74:439-537.
19. Briscoe S, Coumarelos C. New South Wales Drug Court: monitoring report. Report no. 52. Sydney: New South Wales Bureau of Crime Statistics and Research, 2000.
20. Peters RH, Hass AL, Murrin MR. Predictors of retention and arrest in drug courts. Nat Drug Court Inst Rev 1999;2:33-60.
21. Deschenes EP, Turner S, Greenwood PW. Drug Court or probation? An experimental evaluation of Maricopa County's Drug Court. Justice Syst J 1995;18:55-73.
22. Spohn C, Piper RK, Martin T, Frenzel ED. Drug courts and recidivism: the results of an evaluation using two comparison groups and multiple indicators of recidivism. J Drug Issues 2001;31:149-76.
23. Peters RH, Murrin MR. Effectiveness of treatment-based drug courts in reducing criminal recidivism. Crim Justice Behav 2000;27:72-96.
24. Wolfe WJG, Termondt J. A drug court outcome evaluation comparing arrests in a two year period. J Drug Issues 2002;32:1155-72.
25. Goldkamp JS, Weiland D. Assessing the impact of Dade County's felony drug court: final report. Philadelphia: PA Crime and Justice Research Institute, 1993.
26. Deschenes EP, Turner S, Greenwood PW, Chiesa J. An experimental evaluation of drug testing and treatment interventions for probationers in Maricopa County, Arizona. Unrestricted Draft Series: RAND; 1996 July 1996. Report no. DRU-1387-NIJ.
27. Brewster M. An evaluation of the Chester County (AP) Drug Court Program. J Drug Issues 2001;31:177-206.
28. Freeman K. New South Wales Drug Court evaluation: health, well-being and participant satisfaction. Sydney: New South Wales Bureau of Crime Statistics and Research, 2002.
29. Ware J, Snows K, Kosinski M, Grandek B. SF-36 Health Survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center, 1993.
30. Darke S, Ward J, Zador D, Swift G. A scale for estimating the health status of opioid users. Br J Addict 1991;86:1317-22.
31. Adelkan M, Green A, Dasgupta N, Tallack F, Stimson G, Wells B. Reliability and validity of the Opiate Treatment Index among a sample of opiate users in the United Kingdom. Drug Alcohol Rev 1996;15:261-70.
32. Sanson-Fisher R, Perkins J. Adaptation and validation of the SF-36 Health Survey for use in Australia. J Clin Epidemiol 1998;11:961-7.
33. Dobinson I, Ward P. Drugs and crime: a survey of NSW prison property offenders. Sydney: NSW Bureau of Crime Statistics and Research, 1985.
34. ABS. National health survey SF-36 population norms, Australia, 1995. Report No.: Cat. No. 4399.0. Canberra: Australian Bureau of Statistics, 1997.
35. Gossop M, Marsden J, Stewart D, Treacy S. Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study. Drug Alcohol Depend 2001;62:255-64.
36. Hubbard R, Marsden J, Radial J, Harwood H, Cavanaugh E, Ginzberg H. Drug abuse treatment: a national study of effectiveness. London: Chapel Hill, 1989.
37. Sells SB, Simpson DD. The case for drug abuse treatment effectiveness, based on the DARP research program. Br J Addict 1980;75:117-31.
38. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend 1997;47:227-35.
39. Ward J, Mattick RP, Hall W. How long is long enough? Answers to questions about the duration of methadone maintenance treatment. In: Ward J, Mattick RP, Hall W, eds. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood, 1998:305-36.
40. Zhang Z, Friedmann PD, Gerstein DR. Does retention matter? Treatment duration and improvement in drug use. Addiction 2003;98:673 - 84.
41. Simpson DD, Joe GW, Brown B. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcomes Study (DATOS). Psychol Add Behav 1997; 11:294-307.
42. Gaughwin M, Solomon P, Ali R. Correlates of retention on the South Australian Methadone Programme 1981-91. Aust NZ J Public Health 1998;22:771-6.
43. Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer, 1991.
44. Caplehorn JR, Lumley TS, Irwig L. Staff attitudes and retention of patients in methadone maintenance programs. Drug Alcohol Depend 1998;52:57-61.
45. Simpson D, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy 1993;30:357-68.
46. Prochaska J, Di Clemente C. Towards a comprehensive model of change. In: Miller WR, Heather N, eds. Treating addictive behaviour: processes of change. New York: Plenum Press, 1986:3-27.
47. Joe GW, Simpson DD, Broome KM. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction 1998;93:1177-90.
48. De Leon G, Jainchill N. Circumstance, motivation, readiness and suitability as correlates of treatment tenure. J Psychoact Drugs 1986;18:203-8.
49. Young D, Belenko S. Programme retention and perceived coercion in three models of mandatory drug treatment. J Drug Issues 2002;32:297-328.
50. Anglin D, Brecht M, Maddahian E. Pretreatment characteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology 1989;27:537-57.
51. Brecht ML, Anglin MD, Wang JC. Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients. Am J Drug Alcohol Abuse 1993;19:89-106.
52. Broome KM, Knight DK, Knight K, Killer ML, Simpson DD. Peer, family, and motivational influences on drug treatment process and recidivism for probationers. J Clin Psychol 1997;53:387-97.
53. Belenko S. Research on drug courts: a critical review. Nat Drug Court Inst Rev 1998;1:1-42.
54. Drug court activity update: summary information on all programs and detailed information on adult drug courts: Office of Justice Programs Drug Court Clearinghouse and Technical Assistance Project, 2001.
55. Lawrence R, Freeman K. Design and implementation of Australia's first drug court. Aust NZ J Criminol 2002;35:63-78.
56. Taplin S. The New South Wales Drug Court evaluation: a process evaluation. Sydney: NSW Bureau of Crime Statistics and Research, 2002.